Jiangsu Hengrui Pharmaceuticals Co., Ltd. (0BO)

Profile

https://www.hengrui.com

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. Its current portfolio spans oncology, cardiovascular and metabolic diseases, autoimmune conditions, pain management, anti-infectives, and other therapeutic areas, reflecting a broad presence across major treatment categories. The company is also known for offering surgical drugs, contrast agents, and interventional imaging solutions, supporting both hospital-based care and specialty medicine use. Jiangsu Hengrui Pharmaceuticals Co., Ltd. operates as a research-driven drug developer with a diversified pipeline and a strong emphasis on high-quality products for unmet medical needs. In the financial markets, it is recognized as a leading Chinese pharmaceutical group with a significant role in innovative drug development and commercialization across domestic and international healthcare markets.